RxDoctor Payments Data

Adrian Goldstein, MD

Anatomic Pathology · Lexington, MANPI 1316989395

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 23 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 18.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $311 and has fallen 90.7% since, to $29 in 2021. That places this record below the midpoint for anatomic pathology clinicians in MA, where the typical reported total is $330.

$416in general payments, 2019–2025

Across 23 payments — averaging $18.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$77
  • AbbVie$63
  • Mayne Pharma Commercial LLC$55
  • Sanofi$45
  • Bristol Myers Squibb$42
  • Ortho Dermatologics, A Division Of Bausch Health US, LLC$33
  • plus $100 from 5 others

What the payments were for

  • Food & beverage$416100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$416 in reported general payments places this provider in the 50th percentile of 119 anatomic pathology providers in Massachusetts.

See all anatomic pathology providers in Massachusetts →

Medicare billing

Part B allowed, 2024
$102,902
Medicare patients
1,420
Services billed
3,140

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology in Lexington

See the full list for Massachusetts →

Where these figures come from

Is this you, or does something look wrong? →